Evogene Ltd. (EVGN) Balance Sheet

NASDAQ: EVGNAssets, liabilities, debt and equity over 10 years.

EVGN balance sheet, 2025

December 31, 2025 · U.S. dollars

$20.0M assets = $8.1M liabilities + $12.0M equity

What it owns$20.0MCash & ST investments: $13.0M (64.6%)Cash & ST investments$13.0M · 65%Receivables: $1.4M (6.9%)Receivables $1.4MInventory: $210,000 (1.0%)Other current: $1.1M (5.4%)PP&E: $2.6M (13.1%)PP&E$2.6M · 13%LT investments: $43,000 (0.2%)Other non-current: $1.7M (8.7%)Other non-current $1.7M=How it is financed$20.0MCurrent liabilities: $3.4M (17.2%)Current liabilities$3.4M · 17%Other LT liabilities: $4.6M (23.1%)Other LT liabilities$4.6M · 23%Shareholders’ equity: $12.0M (59.7%)Shareholders’ equity$12.0M · 60%

Both columns are drawn to the same scale: what EVGN owns equals what it owes plus shareholders’ equity. Hover a block for its value.

EVGN financial health

Current ratio4.54
Comfortable · current assets cover current liabilities 4.54×
Equity / assets−0.4%
Thin equity · of assets funded by shareholders
Cash / debt589.4%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

EVGN balance sheet trends, 2016–2025

Evogene Ltd. balance sheet trends
MetricTrendThenLatestChange
Total assets$96.0M2016$20.0M2025−16.0%/yr
Total liabilities$8.7M2016$8.1M2025−0.8%/yr
Shareholders’ equity$87.3M2016−$82,0002025—
Cash & short-term investments$88.1M2016$13.0M2025−19.2%/yr
Total debt$2.7M2016$2.2M2025−2.2%/yr
Net cash (debt)$85.4M2016$10.8M2025−$74.7M
Working capital$84.3M2016$12.2M2025−$72.1M
Book value per share$3.432016−$0.012025—
Current ratio17.1320164.542025−12.59
Debt / equity0.0320160.952023+0.92
Shares outstanding25.4M20167.9M2025−12.2%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

EVGN assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

EVGN liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

EVGN debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

EVGN balance sheet

Evogene Ltd. annual balance sheet
2025202420232022202120202019201820172016
Assets
Cash & short-term investments$13.0M$15.3M$31.1M$35.4M$53.9M$48.2M$46.9M$54.5M$71.8M$88.1M
Cash & equivalents$13.0M$15.3M$20.8M$29.0M$32.3M$46.2M$34.7M$5.8M$3.4M$3.2M
Short-term investments$32,000$10,000$10.3M$6.4M$21.5M$2.0M$12.1M$48.7M$68.3M$84.9M
Receivables$1.4M$1.5M$804,000$803,000$1.2M$2.2M$1.2M$746,000$813,000$1.2M
Inventory$210,000$1.8M$76,000$566,000$92,000−$1.4M−$894,000−$444,000−$8.3M−$13.1M
Other current assets$1.1M$3.0M$2.5M$1.0M$1.8M$2.8M$1.8M$719,000$8.6M$13.3M
Total current assets$15.6M$21.6M$34.5M$37.8M$56.9M$51.8M$49.0M$55.5M$72.8M$89.5M
Property, plant & equipment (net)$2.6M$4.3M$3.4M$4.1M$4.2M$3.9M$5.3M$3.2M$4.8M$6.5M
Goodwill & intangible assets$0$12.2M$13.2M$14.1M$15.2M$16.1M$17.1M$0$0$0
Long-term investments$43,000$82,000$0$0$0$0$0$0$0$0
Other non-current assets$1.7M$1.7M$28,000$168,000$25,000$9,000$9,000$19,000$19,000$13,000
Total assets$20.0M$39.9M$51.1M$56.1M$76.3M$71.9M$71.4M$58.7M$77.6M$96.0M
Liabilities
Accounts payable$639,000$1.2M$1.8M$1.0M$1.5M$863,000$1.0M$1.0M$1.1M$1.3M
Short-term debt$716,000$11.0M$853,000$884,000$974,000$777,000$895,000$2.0M$2.8M$2.7M
Deferred revenue$73,000$683,000$750,000$101,000$264,000$119,000$423,000$1.4M$620,000$1.1M
Total current liabilities$3.4M$18.7M$6.9M$5.6M$6.9M$9.7M$5.7M$5.4M$4.7M$5.2M
Long-term debt$0$0$10.4M$10.1M$0$0$2.1M$0$0$0
Lease obligations$2.2M$2.5M$1.1M$1.8M$2.7M$2.4M$3.0M———
Other long-term liabilities$4.6M$6.3M$5.1M$5.6M$6.0M$5.4M$3.3M$3.0M$3.6M$3.5M
Total liabilities$8.1M$25.0M$22.4M$21.3M$12.9M$15.0M$11.1M$8.4M$8.2M$8.7M
Shareholders' equity
Common stock & paid-in capital$488,000$363,000$286,000$235,000$234,000$200,000$142,000$142,000$142,000$141,000
Retained earnings (deficit)−$282.6M−$274.1M−$257.6M−$233.7M−$207.1M−$179.3M−$155.9M−$137.8M−$117.0M−$96.2M
Accumulated other comprehensive income$282.0M$272.3M$269.4M$261.4M$260.5M$225.1M$205.9M$187.7M$372.5M$183.3M
Minority interest$12.1M$16.3M$16.6M$6.9M——————
Total shareholders' equity−$82,000−$1.5M$12.1M$27.9M$53.7M$46.0M$50.1M$50.1M$69.4M$87.3M
Key figures
Total debt$2.2M$12.9M$11.5M$11.9M$2.7M$2.4M$3.0M$2.0M$2.8M$2.7M
Net cash (debt)$10.8M$2.4M$19.6M$23.4M$51.2M$45.8M$43.9M$52.4M$68.9M$85.4M
Working capital$12.2M$2.9M$27.5M$32.1M$50.0M$42.1M$43.3M$50.1M$68.1M$84.3M
Tangible book value−$82,000−$13.6M−$1.1M$13.8M$38.4M$29.9M$33.1M$50.1M$69.4M$87.3M
Book value per share−$0.01−$0.25$2.64$6.78$1.31$1.26$1.95$1.94$2.70$3.43
Shares outstanding7.9M5.7M4.6M4.1M41.0M36.6M25.8M25.8M25.7M25.4M
Current ratio4.541.154.966.718.275.368.5310.2215.6117.13
Quick ratio4.160.904.596.438.005.218.3710.1715.5617.09
Debt / equity——0.950.430.050.050.060.040.040.03
Equity / assets−0.4%−3.6%23.6%49.8%70.3%64.0%70.3%85.3%89.4%90.9%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 26, 2026); data from EODHD.

EVGN financial position

At the end of fiscal 2025 (December 31, 2025), Evogene had total assets of $20.0 million (down 49.7% from a year earlier), total liabilities of $8.1 million and shareholders' equity of -$0.1 million. It held $13.0 million in cash and short-term investments against $2.2 million of debt, a net cash position of $10.8 million. Its current ratio was 4.54. In the latest quarter (ended June 30, 2026) total assets were $13.4 million and equity -$3.3 million.

Related: EVGN income statement, EVGN cash flow statement, EVGN key metrics. See the EVGN stock overview for the latest quote and news.

EVGN balance sheet FAQ

What are Evogene's total assets?

Evogene reported total assets of $20.0 million at the end of fiscal 2025 (December 31, 2025), compared with $39.9 million a year earlier.

How much debt does Evogene have?

Evogene had $2.2 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was —.

How much cash does Evogene have?

Evogene held $13.0 million in cash and short-term investments at the end of fiscal 2025; with $2.2 million of debt that is net cash of $10.8 million.

What is Evogene's book value?

Evogene's shareholders' equity (book value) was -$0.1 million at the end of fiscal 2025, or −$0.01 per share.

What is Evogene's current ratio?

Evogene had current assets of $15.6 million and current liabilities of $3.4 million, a current ratio of 4.54 (it can cover its short-term obligations).

Biotechnology: balance sheet